Afyren SAS (ALAFY.PA) stock: key figures, P/E, revenue and dividend
Materials · Specialty Chemicals · France · ISIN FR0014005AC9
Afyren SAS financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.86 m EUR | 2.27 m EUR |
| Gross profit | -174,000.00 EUR | -5.49 m EUR |
| Operating income | -6.08 m EUR | -7.67 m EUR |
| EBIT | -9.66 m EUR | -7.67 m EUR |
| Net income | -9.75 m EUR | -14.37 m EUR |
| Diluted EPS – continuing operations | -0.37 EUR | -0.53 EUR |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Afyren SAS
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company's products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.
More stocks
- Jeil Pharmaceutical Co Ltd (271980.KS)
- Suzhou Shijing Environmental Technology Co.Ltd. (301030.SZ)
- Shimmick Corp (SHIM)
- Sidus Space Inc. (SIDU)
- Biotalys NV (BTLS.BR)
- Oxford Square Capital Corp. (OXSQ)
- Ctek AB (CTEK.ST)
- Waton Financial Limited Ordinary Shares (WTF)
- DK-Lok Corporation (105740.KQ)
- Korea Petroleum Industries Co (004090.KS)
- Easywell Biomedicals Inc. (1799.TWO)
- United Purification Technology Co., Ltd. (6977.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.